6-K ·Filed Oct 20, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the November 5 conference call for Q3 2026 financial results and pipeline updates. No immediate trading catalyst from this filing alone.
Latest settled — T+5d ⚠ clustered
IPHA ▼ -6.21% at T+5d
NEUTRAL call -6.21% · α vs SPY -6.29% · entry $1.58 → $1.48
T+1d
-0.51%
call -0.51% · α -1.03%
$1.57
settled 6d ago
T+5d
-6.21%
call -6.21% · α -6.29%
$1.48
settled 10h ago
T+20d
Pending
in 21d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Innate Pharma filed a 6-K announcing a conference call on November 5, 2026, to provide a business and financial update for the third quarter of 2026. No financial results, clinical data, or material business developments were disclosed in the filing. This is a routine administrative announcement with no actionable information for traders.
Key Facts
- Conference call scheduled for November 5, 2026, at 2 p.m. CET / 8 a.m. ET.
- Call participants include CEO, CMO, COO, CFO, and VP of IR.
- No financial figures, clinical data, or guidance provided in the filing.
- Filing is a routine 6-K for a conference call announcement.
Financial Impact
No financial impact disclosed.
Risk Factors
- No material information disclosed; stock may trade on unrelated news or sector sentiment.
- Conference call may reveal negative data or financial results.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-066382 |
| Document: a261020_6k.htm | 0001628280-26-066382 |
| Document: 0001628280-26-066382-index-headers.html | 0001628280-26-066382 |
| Document: 0001628280-26-066382-index.html | 0001628280-26-066382 |
| Document: 0001628280-26-066382.txt | 0001628280-26-066382 |
13 reports for IPHA
0% Hit rate @ T+20 Went positive at some point 0 of 3 best @ T+1▼ −0.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $1.54 | awaiting T+20 | — | $1.48 (−3.90%) |
Oct 21, 2026 6d ago | 6-K | $1.57 | awaiting T+20 | — | $1.48 (−5.73%) |
Oct 20, 2026 7d ago | 6-K | $1.58 | awaiting T+20 | — | $1.48 (−6.21%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 16, 2026 5w ago | Press Release | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 10, 2026 6w ago | 6-K | $1.88 $1.48 | ▼ −21.28% | ▼ −23.40% | $1.48 (−21.28%) |
Sep 2, 2026 7w ago | 6-K | $2.17 $1.63 | ▼ −24.88% | ▼ −24.80% | $1.48 (−31.80%) |
Aug 14, 2026 10w ago | 6-K | $2.18 $1.85 | ▼ −15.14% | ▼ −13.15% | $1.48 (−32.11%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Wed (15h 42m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers